The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Sp699
PREVENTATIVE HEPATOLOGY: WHAT IS IT AND WHY IS IT IMPORTANT?
ASSOCIATION OF GLUCAGON-LIKE PEPTIDE-1 AGONISTS WITH CIRRHOSIS AND HEPATOCELLULAR CANCER IN METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
Background: Current non-invasive tests (NITs) utilized to screen and predict liver fibrosis were developed in predominantly Caucasian populations, and their performance in non-Caucasians is not well known…